The purpose of these measures is to promote strategic Translational Research projects in Rare Diseases between the CIBERER and the hospitals in the National Health System which are doing prominent research work in Rare Diseases.
They are intended to further translation of the knowledge generated through research of CIBERER groups, either in the form of new diagnostic technologies, the delineation of new diagnostic biomarkers and monitoring and therapeutic response, development of new therapies, repositioning of drugs for rare diseases or other tools of use for clinical practice.
